Genewise Bio

Beijing BOE Microbial Technology Co., Ltd. is a strategic subsidiary of the BOE Group. As an overall in vitro diagnostic solution provider, it integrates self-innovated microfluidic technology as its core with diagnostic reagents and complete equipment. The company possesses a medical-engineering integrated R&D platform for microfluidic chip design and processing, biological testing reagents, and medical testing devices, along with a 10,000-grade cleanroom facility that complies with GMP production management standards. Genewise Bio is committed to becoming a global leader in the molecular diagnostics industry, empowering China's precision healthcare system and tiered medical treatment system construction. With strong innovative research capabilities, several rapid test kits from Genewise Bio have entered the registration testing and clinical trial stages.